Olema Pharmaceuticals, Inc.·4

Feb 2, 5:31 PM ET

Kovacs Shane William Charles 4

4 · Olema Pharmaceuticals, Inc. · Filed Feb 2, 2023

Insider Transaction Report

Form 4
Period: 2023-02-01
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-01+200,000200,000 total
    Exercise: $4.87Exp: 2033-01-31Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION